Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 30 kwi 2018 · Infection with hepatitis E virus (HEV) is a significant cause of morbidity and mortality, representing an important global health problem. Our understanding of HEV has changed completely over the past decade. Previously, HEV was thought to be limited to certain developing countries.

  2. 9 sie 2023 · Hepatitis E virus (HEV) is one of the most common causes, yet least diagnosed etiologies, of acute viral hepatitis [1]. HEV infection has a global distribution, with distinct differences in transmission and disease outcomes in resource-rich versus resource-limited areas.

  3. 20 gru 2020 · Abstract. Hepatitis E virus infection can cause chronic hepatitis in immunocompromised patients with significant chance of progressive fibrosis and possibly cirrhosis. The aim of this systematic review was to summarize the efficacy and safety of the various treatment options for chronic hepatitis E. We performed a systematic literature search.

  4. 17 lip 2020 · Ribavirin therapy for a period of 3 months is the drug of choice for severe acute hepatitis, acute-on chronic liver failure, and chronic infections from hepatitis E virus in immunocompromised patients who are unresponsive to decreased immunosuppression.

  5. 1 cze 2018 · As a cause of significant morbidity and mortality, infection with hepatitis E virus (HEV) represents an important global public health problem. The European Association for the Study of Liver (EASL) invited a panel of experts in the field to develop Clinical Practice Guidelines (CPGs) with a particular focus on HEV genotype (gt) 3.

  6. 7 maj 2021 · Hepatitis E virus (HEV) is one of the leading causes of acute hepatitis in developing and developed countries, infecting about 20 million people in developing countries, resulting in 3.3 million symptomatic cases and 44 000 deaths per year. 1 HEV not only infects hepatocytes, but also extrahepatic tissues. 2 Studies on HEV seroprevalence have sh...

  7. Most guidelines state that testing for hepatitis E infection should be considered in immunocompetent patients with elevated aminotransferases or extrahepatic manifestations (e.g., neurologic symptoms, acute pancreatitis, thrombocytopenia, and unexplained hemolytic anemia).4,5,7,8,10 A Swiss multicenter, prospective, observational study analyzed ...